Equipoise (Boldenone Undecylenate)

Functions and Traits

Equipoise (Boldenone Undecylenate) is a structurally altered form of testosterone. It is a very slight change in an added double bond at the carbon one and two position.

This double bond greatly reduces the hormone’s androgenicity, as well as estrogenic nature. It is then attached to the very large or long Undecylenate ester, which is responsible for controlling the release of the hormone once administered into the body.

Due to its structural change, Equipoise only aromatizes at approximately 50% the rate of testosterone. Estrogenic side effects are possible, but the odds are highly in the individual’s favor compared to testosterone. It is not as powerful of a mass builder as testosterone, not even close, but the reduced estrogenic activity should allow the individual to make cleaner gains through supplementation.

The Undecylenate ester allows for a peak release in Boldenone approximately 3­4 days after injection, with a slow continuous release of the hormone to follow for approximately 21 days.

Due to its structural change, Equipoise only aromatizes at approximately 50% the rate of testosterone. Estrogenic side effects are possible, but the odds are highly in the individual’s favor compared to testosterone. It is not as powerful of a mass builder as testosterone, not even close, but the reduced estrogenic activity should allow the individual to make cleaner gains through supplementation.

In many ways, the increase in red blood cells provided by Equipoise can be fast and rapid, but may not present a significant advantage or disadvantage compared to most anabolic steroids when used responsibly. Without question, a moderate increase in cell production would be very advantageous for most any athlete.

Benefits and Side Effects

As a veterinarian steroid, Equipoise is well­ known for its use in horses, hence the name “Equipoise” and its similarity to the word “Equestrian.” EQ is often given to horses in an effort to increase lean body weight, which is in part due to the steroid ability to increase appetite.

An increased appetite is well noted among many performance enhancing athletes that use Equipoise, however, it doesn’t appear to affect everyone the same. Many who use the anabolic steroid report no increase in appetite, it tends to be highly individualistic, but it could be useful for those struggling to consume needed calories.

The effects of Equipoise are fairly straightforward. This is a generally well­ tolerated anabolic steroid that presents notable anabolic activity in most users in a clean and even fashion.

Outside of performance enhancement use, Boldenone did enjoy some success as a human grade steroid for a time. The steroid had some success in treating muscle wasting diseases and osteoporosis, but would ultimately give way to other steroidal options.

Watch out for these side effects:

  • Androgenic: Equipoise can produce androgenic side effects such as acne, accelerated hair loss in those predisposed to male pattern baldness and body hair growth. However, the overall androgenicity of this steroid is greatly reduced due to the structural nature that creates EQ in its double bond at the carbon one and two position. Such side effects of Equipoise are still possible, but they will be strongly linked to genetic predisposition, but most will find the threshold is fairly high.
  • Estrogenic: The Boldenone hormone does not aromatize heavily, but it is aromatized to estrogen nonetheless. This is due to the testosterone hormone’s interaction with the aromatase enzyme. High levels of estrogen can prove problematic in their promotion of gynecomastia, excess water retention and high blood pressure if water retention becomes severe.
  • Cardiovascular: The relative cardiovascular strain brought on by Equipoise should be much less than many anabolic steroids, especially those of an oral nature. Boldenone does have the ability to negatively affect cholesterol ratios, particularly in its ability to suppress HDL levels. However, it should not be of an extreme nature, and should be well within the realm of control for most healthy adults. Of course, the introduction of an AI to combat estrogenic effects will potentially enhance the improper lipid profiles, and should be considered when planning your cholesterol management.
  • Hepatotoxicity: Boldenone is not a hepatotoxic anabolic steroid and will present no stress or damage to the liver.
  • Testosterone: Like all anabolic steroids, Equipoise will suppress natural testosterone production. The rate of suppression varies from one steroid to the next, and while EQ is not the most suppressive steroid it will produce a significant reduction in total
serum testosterone levels. For this reason, most men will need to include exogenous testosterone in their total stack when using EQ. The form of testosterone is inconsequential.

Dosage and Administration

Standard Equipoise doses will normally fall in the 200­-400 mg per week range. Most men will find 400 mg to be very well­ tolerated and generally the minimal amount of EQ they’ll want to use. Many will also find 600 mg per week to be extremely well­ tolerated with side effects being extremely easy to control.

However, such doses will increase estrogenic potential. Due to the long activity of the steroid, most men could easily get by with one injection per week, but splitting the weekly dose into 2-­3 smaller injections will cut down on total injection volume.

Further, some have reported side effects are even easier to control with a smaller more frequent injection schedule despite an extremely long half ­life. Regardless of the total dose, Equipoise should be used for a minimum of 8 weeks.